RIPCORD 2: routine pressure wire assessment influences management strategy of coronary angiography
Video by PCR via YouTube
Go to Source
Panos Xaplanteris interviews Nick Curzen, principal investigator of RIPCORD 2 about the results of this trial presented at #ESCCongress 2021.
How does the trial differ from previous studies on physiology driven revascularisation ? Was every troponinemia at the emergency department considered to be a NSTEMI, thus eligible for inclusion? Did results differ between the two patient groups? Treatment options for FFR positive patients included OMT, PCI and CABG – how did these groups fare over time? How do results differ from the FUTURE trial? Is there a RIPCORD 3 underway? And more!
View more ESC Congress 2021 coverage on PCRonline here: https://www.pcronline.com/News/Whats-new-on-PCRonline/2021/ESC-2021/PCRonline-ESC-Congress-2021